Revance Therapeutics
RVNC
#6431
Rank
NZ$0.90 B
Marketcap
$8.66
Share price
-0.56%
Change (1 day)
-54.72%
Change (1 year)

Revance Therapeutics (RVNC) Fails to deliver data

Key failure to deliver metrics for Revance Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Revance Therapeutics (RVNC) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Revance Therapeutics (RVNC) - since 2014

Volume in USD (price x number of shares), data since 2014

Revance Therapeutics (RVNC) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$6.57 M-85.48%
2023NZ$45.25 M383.15%
2022NZ$9.36 M-6.12%
2021NZ$9.97 M-56.82%
2020NZ$23.1 M668%
2019NZ$3 M-97.15%
2018NZ$0.10 B815.52%
2017NZ$11.51 M5.25%
2016NZ$10.93 M-46.65%
2015NZ$20.5 M-9.25%
2014NZ$22.59 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
NZ$0.01 MNZ$0.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$90.55 MNZ$0.28 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.11 MNZ$63.51 M๐Ÿ‡บ๐Ÿ‡ธ USA